Request a copy of the file

Enter the following information to request a copy for the following item: Afatinib versus methotrexate as second-line treatment in patients with recurrent or metastatic squamous-cell carcinoma of the head and neck progressing on or after platinum-based therapy (LUX-Head & Neck 1): an open-label, randomised phase 3 trial

Requesting the following file: 2015_Machiels_Lancet_Oncol.pdf